Novavax Delays Phase 3 COVID-19 Vaccine Trial Again in the U.S.

[Asia Economy Reporter Kiho Sung] Novavax has once again postponed the Phase 3 clinical trial of its novel coronavirus disease (COVID-19) vaccine candidate in the United States.

Novavax had originally planned to start the clinical trial in the U.S. in mid-last month but postponed it once due to issues with expanding vaccine production. This is the second time the trial has been delayed.

Novavax expects to begin the clinical trial in the U.S. in a few weeks.